IRS Says Mylan Can't Deduct $50M Patent Litigation Costs
Pharmaceutical giant Mylan Inc. should not win a $50 million tax deduction for patent litigation costs because those expenses were part of the government approval process for generic drugs, the IRS...To view the full article, register now.
Already a subscriber? Click here to view full article